The FDA updated its draft guidance on its handling of off-label communication for its regulated products, Gastroenterology and Endoscopy News reports.
GI & Endoscopy
A study in JAMA Oncology, sought to answer whether diets rich in whole grains and fiber increase or decrease colorectal cancer by studying the presence of Fusobacterium nucleatum in tumor tissue.
Tokyo's Astellas Pharma and Cambridge, Mass.-based Ironwood Pharmaceuticals announced positive top-line results from their combined phase III trial for chronic constipation drug linaclotide.
Here are the five most read gastroenterology/endoscopy stories for Jan. 23 to Jan. 27, 2017.
The National Institute for Health and Care Excellence is evaluating Amsterdam-Zuidoost, Netherlands-based Norgine's Endocuff Vision.
Advertisement
Throughout the United States, healthcare facilities hospitalize millions of Americans to treat various digestive diseases.
Xuong Lu, MD, is a gastroenterologist at Pittsburgh Gastroenterology Associates.
Here are two gastroenterologists in the news this past week.
American College of Gastroenterology has released new clinical guidelines in the American Journal of Gastroenterology.
Synergy Pharmaceuticals has received FDA approval for Trulance (plecanatide), a treatment for adult chronic idiopathic constipation.